Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse

NCT01018563 is registered in ClinicalTrials.gov with Morphotek as lead sponsor.

NCT NCT01018563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01018563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Lead sponsor
Morphotek
Phase
Phase 2
Overall status
Terminated
Start date
January 13, 2010
Completion date
March 5, 2013
Enrollment
3 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer